Ola Landgren, Professor of Medicine, Chief of the Division of Myeloma at University of Miami and Leader of Experimental Therapeutics Program at Sylvester Comprehensive Cancer Center, shared a post on LinkedIn:
“We’re thrilled to welcome Professor Brian Walker to the Sylvester Myeloma Institute at the Sylvester Comprehensive Cancer Center, University of Miami! His expertise will be a huge asset to our mission of advancing myeloma research and treatment. Welcome to the team, Dr. Walker!
Dr. Walker will be using patient-derived xenografts to model how different myeloma subgroups respond to new treatments – helping to shape the future of precision medicine!
Epigenetics and Myeloma: His research shows that DNA methylation and histone modifications play a key role in prognosis and gene regulation, evolving throughout disease progression.
Single-Cell Analysis: Myeloma is complex, and we’re leveraging cutting-edge single-cell tech to uncover how genomic heterogeneity drives tumor evolution and treatment response.
Follow us for more updates on our mission to advance myeloma research in beautiful Miami!”